“This scenario demonstrates FDA and the Justice Office’s commitment to operate collaboratively to hold drug companies accountable if they are unsuccessful to share correct details with overall health care specialists in regards to the dangers and benefits of opioids.” Firsthand practical experience: Our team has many years of collective co